Concepedia

Diederik van Bodegom

DV

11

Publications

1.3K

Citations

11

H-Index

2006

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Harvard University Press

Broad Institute

Brigham and Women's Hospital

Diederik van Bodegom is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

2006–2016

11

Publications

11

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane et al. · Blood · 2013 · 423 citations · Full text

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 161 citations · Full text

p53 regulates a non-apoptotic death induced by ROS

Joan Montero, Chaitali Dutta, Diederik van Bodegom et al. · Cell Death and Differentiation · 2013 · 137 citations · Full text

, , +4

Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation

Andrew A. Lane, Bjoern Chapuy, Charles Y. Lin et al. · Nature Genetics · 2014 · 131 citations · Full text

Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp et al. · Cancer Cell · 2015 · 120 citations · Full text

, , +6

Rows per page

1–5 of 11